SG Americas Securities LLC Boosts Stake in Kenvue Inc. $KVUE

SG Americas Securities LLC increased its position in shares of Kenvue Inc. (NYSE:KVUE) by 16.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 174,800 shares of the company’s stock after buying an additional 25,096 shares during the quarter. SG Americas Securities LLC’s holdings in Kenvue were worth $3,659,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in KVUE. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in shares of Kenvue by 7.4% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 470,869 shares of the company’s stock worth $9,855,000 after acquiring an additional 32,417 shares during the last quarter. Empower Advisory Group LLC grew its position in Kenvue by 4.9% during the 2nd quarter. Empower Advisory Group LLC now owns 2,531,016 shares of the company’s stock worth $52,974,000 after purchasing an additional 117,841 shares during the last quarter. Advisors Capital Management LLC increased its stake in Kenvue by 7.0% in the second quarter. Advisors Capital Management LLC now owns 1,635,838 shares of the company’s stock valued at $34,238,000 after purchasing an additional 106,677 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. raised its holdings in shares of Kenvue by 59.8% in the second quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 274,375 shares of the company’s stock valued at $5,739,000 after buying an additional 102,683 shares during the last quarter. Finally, Thompson Davis & CO. Inc. acquired a new stake in shares of Kenvue during the second quarter worth about $545,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research report on Tuesday, October 14th. Zacks Research upgraded Kenvue to a “strong sell” rating in a research note on Monday, August 11th. Rothschild & Co Redburn upgraded shares of Kenvue from a “neutral” rating to a “buy” rating and lowered their price objective for the company from $22.50 to $22.00 in a research report on Friday, September 26th. Bank of America dropped their price objective on shares of Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Finally, Barclays raised their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $20.23.

Kenvue Trading Up 0.3%

NYSE:KVUE opened at $16.30 on Wednesday. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The stock has a fifty day moving average price of $16.32 and a two-hundred day moving average price of $19.93. The stock has a market capitalization of $31.22 billion, a price-to-earnings ratio of 21.73, a PEG ratio of 2.40 and a beta of 0.71.

Kenvue (NYSE:KVUE) last issued its earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.27 by $0.01. The company had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business’s revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be issued a $0.2075 dividend. The ex-dividend date of this dividend is Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a yield of 5.1%. Kenvue’s dividend payout ratio (DPR) is 110.67%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.